Results 241 to 250 of about 77,084 (260)

PARP Inhibitors

2006
openaire   +1 more source

Phthalazine derivatives as parp inhibitors

2006
MEVELLEC LAURENCE ANNE, LUDO EDMOND J K, MERTENS JOSEPHUS CAROLUS, VAN DUN JACOBUS A J, SOMERS MARIA V F, WOUTERS WALTER B L   +5 more
openaire   +5 more sources

DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity

Cell, 2018
Jiří Lukáš, Takeo Narita, André Stanlie   +2 more
exaly  

PARP Inhibitors

2008
openaire   +1 more source

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Cancer Cell, 2018
Marieke van de Ven, Haico van Attikum, Marcel A.T.M. van Vugt   +2 more
exaly  

A Pan-Tumor Review of the Role of Poly(Adenosine Diphosphate Ribose) Polymerase Inhibitors

Ca-A Cancer Journal for Clinicians
Jennifer K Litton, Nicolas Sayegh, Chadi Hage Chehade   +2 more
exaly  

Phase I Dose Escalation Study of the PI3kinase Pathway Inhibitor BKM120 and the Oral Poly (ADP Ribose) Polymerase (PARP) Inhibitor Olaparib for the Treatment of High-Grade Serous Ovarian and Breast Cancer

Annals of Oncology, 2017
Gordon B. Mills, David B Solit, W T Barry   +2 more
exaly  

PARP Inhibitors

2017
openaire   +1 more source

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2016
exaly  

An Update on PARP Inhibitors—Moving to the Adjuvant Setting

Nature Reviews Clinical Oncology, 2015
Martine Piccart, Evandro de Azambuja, Amir Sonnenblick   +2 more
exaly